Willingdon Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Willingdon Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$48K	Hold	200	–	–	0.01%	150
2019 Q4	$52K	Hold	200	–	–	0.01%	173
2019 Q3	$54K	Hold	200	–	–	0.01%	166
2019 Q2	$55K	Hold	200	–	–	0.01%	164
2019 Q1	$45K	Hold	200	–	–	0.01%	182
2018 Q4	$37K	Hold	200	–	–	0.01%	194
2018 Q3	$50K	Hold	200	–	–	0.01%	204
2018 Q2	$44K	Hold	200	–	–	0.01%	186
2018 Q1	$38K	Hold	200	–	–	0.01%	178
2017 Q4	$31K	Hold	200	–	–	0.01%	175
2017 Q3	$31K	Buy	+200	New	+$31.6K	0.01%	170

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Willingdon Wealth Management's IDXX Position: Q1 2020 in Review

Willingdon Wealth Management held its Idexx Laboratories (IDXX) position steady in Q1 2020 at 200 shares worth $48K. The position accounts for 0.01% of the portfolio, ranked #150.

Willingdon Wealth Management first reported a position in IDXX in Q3 2017 and has held it in 11 quarters since. The position peaked at $55K in Q2 2019. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

Willingdon Wealth Management held 200 shares of Idexx Laboratories worth $48K as of Q1 2020.
Willingdon Wealth Management left its Idexx Laboratories share count unchanged in Q1 2020.
Idexx Laboratories made up 0.01% of Willingdon Wealth Management's portfolio in Q1 2020, its #150 holding.
Willingdon Wealth Management first reported a position in Idexx Laboratories in Q3 2017 and has held it in 11 quarters since.
Willingdon Wealth Management's Idexx Laboratories position peaked at $55K in Q2 2019.
748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.